Global Insulin Pumps Pipeline Analysis Report 2022: Breakdown by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies


Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to's offering.

The report provides comprehensive information about the Insulin Pumps pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management.


  • Extensive coverage of the Insulin Pumps under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Pumps under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Insulin Pumps Overview

3 Products under Development
3.1 Insulin Pumps - Pipeline Products by Stage of Development
3.2 Insulin Pumps - Pipeline Products by Segment
3.3 Insulin Pumps - Pipeline Products by Territory
3.4 Insulin Pumps - Pipeline Products by Regulatory Path
3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date
3.6 Insulin Pumps - Ongoing Clinical Trials

4 Insulin Pumps - Pipeline Products under Development by Companies
4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development
4.2 Insulin Pumps - Pipeline Products by Stage of Development

5 Insulin Pumps Companies and Product Overview

6 Insulin Pumps- Recent Developments

7 Appendix

Companies Mentioned

  • AMF Medical SA
  • Amrita Vishwa Vidyapeetham
  • Andain, Inc
  • Becton Dickinson and Co
  • Cellnovo Ltd (Inactive)
  • Debiotech SA
  • EOFlow Co Ltd
  • Hospira Inc
  • Insulet Corp
  • Kailian Medical Technology Co Ltd
  • LifeScan Inc
  • MedSolve Technologies, Inc.
  • Medtronic MiniMed Inc
  • Medtronic Plc
  • MicroPort Scientific Corp
  • MicroTech Medical Co Ltd
  • Modular Medical Inc
  • Pennsylvania State University
  • Phluid Corporation
  • PhysioLogic Devices Inc
  • Qlibrium Inc
  • SFC Fluidics LLC
  • Sooil Development Co., Ltd.
  • Spring Health Solutions Ltd.
  • Tandem Diabetes Care Inc
  • Thermalin Inc
  • Triple Jump Israel Ltd
  • University of Limerick
  • Univlabs Technologies Pvt Ltd
  • ViCentra BV
  • Ypsomed Holding AG

For more information about this report visit


Contact Data